Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Human Papillomavirus Vaccines
Scientists at Centers for Disease Control and Prevention describe research in human papillomavirus vaccines
December 16th, 2008
Research findings, 'A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US,' are discussed in a new report. "It has been estimated that genital human papillomavirus (HPV) is the most common sexually transmitted infection in the US. Nononcogenic types, such as HPV type 6 (HPV-6) and HPV-11, can cause benign or low-grade cervical cell changes, genital warts, and recurrent respiratory papillomatosis," investigators in the United States report. "Oncogenic types can cause cervical and other anogenital cancers; oncogenic HPV types are detected in 99% of cervical cancers worldwide. A quadrivalent HPV vaccine to prevent HPV-6, HPV-11,...
Source: Cancer Weekly (2008-12-16)
|
